Matthew Kaplan

Stock Analyst at Ladenburg Thalmann

(3.53)
# 769
Out of 4,492 analysts
20
Total ratings
60.87%
Success rate
2.83%
Average return

12 Stocks

UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48$54
Current: $16.93
Upside: +216.01%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39$40
Current: $21.19
Upside: +88.77%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15$30
Current: $12.61
Upside: +137.91%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5$8.5
Current: $5.89
Upside: +44.31%
United Therapeutics
Aug 3, 2023
Maintains: Buy
Price Target: $256$268
Current: $321.38
Upside: -16.61%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15$16
Current: $16.60
Upside: -3.61%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $4.23
Upside: +25,219.15%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17$23
Current: $0.57
Upside: +3,959.30%
Reneo Pharmaceuticals
Nov 22, 2021
Initiates: Buy
Price Target: n/a
Current: $1.48
Upside: -
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: n/a
Current: $7.69
Upside: -
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: n/a
Current: $9.27
Upside: -
Protara Therapeutics
Jan 22, 2020
Initiates: Buy
Price Target: n/a
Current: $2.36
Upside: -